Contraception process and administration form for the same

Details Contraception process and administration form for the same Contraception process and administration form for the same

2001-09-05

2011-12-13

Hui, San-Ming (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

Reexamination Certificate

active

08076317

ABSTRACT:
Process for hormonal contraception, in which in a plurality of substantially time-unlimited, linked taking periods and optionally having a sequence lasting several years and which in each case comprise at least one taking cycle with a duration-constant taking phase lasting several days within the particular taking period and a taking pause lasting several days, in which taking phase or phases per day administration takes place of a daily unit with at least one contraceptively acting hormone component, such as estrogen and/or gestagen, and in the taking pause or pauses administration takes place either of placebos free from any hormone component or the particular taking pause remains entirely administration-free and the duration of the taking phase or phases of at least the final taking period last at least 22 days, characterized in that the duration of the taking phase or phases in any taking period proceeding a following taking period is shorter than in each case following taking period, as well as administration form for hormonal contraception and in particular for the performance thereof.

REFERENCES:
patent: 5583129 (1996-12-01), Spona et al.
patent: 5898032 (1999-04-01), Hodgen
patent: 6225298 (2001-05-01), Spicer et al.
patent: 6312722 (2001-11-01), Schmidt-Gollwitzer et al.
patent: 43 44 462 (1995-06-01), None
patent: 195 25 017 (1997-01-01), None
patent: 0 911 029 (1999-04-01), None
patent: WO 96 15794 (1996-05-01), None
patent: WO 9804269 (1998-02-01), None
Schwartz et al., “The trimonthly combination oral contraceptive regimen: is it cost effective?”, Contraception, vol. 60, No. 5, 1999, pp. 263-267, XP002196533.
Voogd, “Postponement of Withdrawal Bleeding with a Monophasic Oral Contraceptive Containing Desogestrel and Ethinylestradiol”, Contraception, Aug. 1991, vol. 44, No. 2, pp. 107-112.
Loudon et al., “Acceptability of an oral Contraceptive that Reduces the Frequency of Menstruation: The tri-cycle Pill Regiment”, British Medical Journal, Aug. 20, 1977, pp. 487-490.
European Office Action corresponding to EP 01 962 996.3, dated Mar. 1, 2007.

Affiliated with

Also associated with

Rating

Contraception process and administration form for the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Contraception process and administration form for the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contraception process and administration form for the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4254225